Target intelligence / Profile preview

Nipped-B-like protein (NIPBL)

Target
NIPBL
Molecular classification
Chromosome cohesion factor, Chromatin regulator, Cohesin loading factor, Other (no standard receptor/enzyme classification, but functions in chromosomal biology)
01

Overview

Nipped-B-like protein (NIPBL) is a chromosomal protein required for loading the cohesin complex onto chromatin, ensuring sister chromatid cohesion and proper chromosome segregation during cell division[1][2][3][4][7]. NIPBL forms a complex with MAU2/SCC4, collectively termed the cohesin loading complex, which is essential for cohesin’s association with DNA[2][3][4][7]. Besides its key role in cell division, NIPBL participates in DNA repair, regulation of gene expression, RNA biogenesis, and possibly in developmental signaling pathways (including Wnt signaling)[8][4]. Mutations in the NIPBL gene are the main cause of Cornelia de Lange syndrome, a multisystem developmental disorder characterized by distinctive facial features, growth delay, limb abnormalities, and cognitive disabilities[1][3][4]. NIPBL’s centrality in genome stability, regulation, and development makes it a target of research for understanding cohesinopathies and exploring implications in cancer and regenerative medicine, though no drugs currently target NIPBL directly for therapy[3][4].

Other names
NIPBLdelanginSCC2IDN3CDLSCDLS1IDN3-BNIPBL_HUMANNipped-B homolog (Drosophila)Nipped-B-likeScc2sister chromatid cohesion 2 homolog
02

Mechanism of action

Not applicable; no approved drugs known to target NIPBL directly.

03

Biological functions

Cohesin loading onto chromatinSister chromatid cohesionChromosome segregation during cell divisionDNA repairRegulation of gene expressionRNA processing and biogenesisEmbryonic and tissue development
04

Disease associations

Cornelia de Lange syndrome (primary, developmental disorder)Cohesinopathies (group of disorders)Cancer (chromosomal instability)Other developmental disorders
05

Safety considerations

Essential developmental role, so systemic inhibition or mutation causes severe developmental defects (Cornelia de Lange syndrome), highlighting risk for major toxicity in therapeutic contextsGlobal disruption leads to defects in chromosomal segregation and gene regulation.
06

Interacting drugs

None known (no approved drugs targeting NIPBL directly)
07

Biomarkers

Mutations in NIPBL are biomarkers for Cornelia de Lange syndrome and are used in genetic diagnosis

Beyond the preview

Go deeper on Nipped-B-like protein (NIPBL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nipped-B-like protein (NIPBL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call